for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Medtronic PLC

MDT.N

Latest Trade

106.11USD

Change

-1.65(-1.53%)

Volume

1,708,328

Today's Range

105.97

 - 

108.93

52 Week Range

98.39

 - 

135.84

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Medtronic Announces Results Showing Meaningful Pain Relief Using DTM Spinal Cord Stimulation Endurance Therapy

Jan 14 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC ANNOUNCES RESULTS SHOWING MEANINGFUL PAIN RELIEF USING DTM™ SPINAL CORD STIMULATION ENDURANCE THERAPY.MEDTRONIC PLC - DTM SCS ENDURANCE THERAPY ENABLES LONG-LASTING RECHARGE-FREE PERFORMANCE ON VANTA AND 5-MINUTE RECHARGE ON INTELLIS NEUROSTIMULATORS.MEDTRONIC - 3-MONTH DATA SHOWS THERAPY ENABLES BETWEEN 5.5-7.5 YEARS DEVICE LONGEVITY WHEN PROGRAMMED ON VANTA RECHARGE-FREE NEUROSTIMULATOR.

CMS Expands Diabetes Medicare Coverage To Include CGMs That Integrate With Medtronic Insulin Pumps

Dec 22 (Reuters) - Medtronic PLC <MDT.N>::CMS EXPANDS DIABETES MEDICARE COVERAGE TO INCLUDE CGMS THAT INTEGRATE WITH MEDTRONIC INSULIN PUMPS.MEDTRONIC PLC - CMS WILL EXPAND MEDICARE COVERAGE FOR ALL TYPES OF CONTINUOUS GLUCOSE MONITORS (CGMS), INCLUDING ADJUNCTIVE AND NON-ADJUNCTIVE CGMS.

Medtronic - Does Not Expect Impact From Warning Letter To Total Adjusted EPS Guidance For Q3 Or 2022

Dec 15 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC - DOES NOT EXPECT IMPACT FROM WARNING LETTER TO TOTAL CO ORGANIC REVENUE GROWTH, ADJUSTED EPS GUIDANCE FOR Q3 OR FULL FISCAL YEAR 2022 ISSUED ON NOV 23.MEDTRONIC PLC - NOW EXPECTS DIABETES DECLINES IN HIGH-SINGLE DIGIT RANGE FOR THIRD FISCAL QUARTER AND MID-SINGLE DIGITS RANGE FOR FULL FISCAL YEAR 2022.MEDTRONIC - MODELED PRELIM IMPACT TO TOTAL CO FISCAL YEAR 2023 REVENUE GROWTH IN RANGE OF LESS THAN 0.5 PERCENTAGE POINTS TO ABOUT 1 PERCENTAGE POINT OF GROWTH.

Medtronic Says Entered Into Amendment And Extension Agreement To Credit Agreement

Dec 14 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC PLC - ENTERED INTO AMENDMENT NO. 3 AND EXTENSION AGREEMENT TO AMENDED AND RESTATED CREDIT AGREEMENT.MEDTRONIC PLC - THIRD AMENDMENT MODIFIES ORIGINAL CREDIT AGREEMENT TO EXTEND MATURITY DATE FROM DECEMBER 12, 2025 TO DECEMBER 12, 2026.MEDTRONIC PLC - THIRD AMENDMENT MODIFIES ORIGINAL CREDIT AGREEMENT TO REMOVE CAP ON NUMBER OF MATURITY EXTENSIONS AVAILABLE TO CO.MEDTRONIC PLC - THIRD AMENDMENT MODIFIES ORIGINAL CREDIT AGREEMENT TO MODIFY CERTAIN CATEGORIES OF CREDIT FACILITY PRICING.Further company coverage: MDT.N. ((Reuters.Briefs@thomsonreuters.com;)).

Vincent Medical Says Unit Entered A Distribution Agreement With Medtronic

Nov 29 (Reuters) - Vincent Medical Holdings Ltd <1612.HK>::UNIT ENTERED A DISTRIBUTION AGREEMENT WITH MEDTRONIC.APPOINTED MEDTRONIC AS ITS PREFERRED DISTRIBUTOR OF INSPIRED TM HUMIDIFIER AND ACCESSORIES, AMONG OTHERS, IN OVER 30 COUNTRIES.

Medtronic Posts Profit Of 97 Cents Per Share

Nov 23 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $1.32.Q2 GAAP EARNINGS PER SHARE $0.97.REAFFIRMS FY NON-GAAP EARNINGS PER SHARE VIEW $5.65 TO $5.75 INCLUDING ITEMS.MARKET PROCEDURE VOLUMES IMPACTED BY COVID-19 RESURGENCE.Q2 REVENUE RESULTS REFLECT UNFAVORABLE MARKET IMPACT OF COVID-19 AND HEALTH SYSTEM LABOR SHORTAGES ON MEDICAL DEVICE PROCEDURE VOLUMES.QTRLY REVENUE OF $7.8 BILLION INCREASED 3% REPORTED.QTRLY CARDIOVASCULAR REVENUE OF $2.827 BILLION INCREASED 4% AS REPORTED AND 3% ORGANIC.QTRLY MEDICAL SURGICAL REVENUE OF $2.299 BILLION INCREASED 1% AS REPORTED AND WAS FLAT ORGANIC.EXPECT MARKETS TO CONTINUE TO BE AFFECTED BY PANDEMIC IN SECOND HALF OF OUR FISCAL YEAR.Q2 EARNINGS PER SHARE VIEW $1.29, REVENUE VIEW $7.96 BILLION -- REFINITIV IBES DATA.EXCLUDING IMPACT OF VENTILATOR SALES DECLINES, QTRLY MEDICAL SURGICAL REVENUE INCREASED 6% ORGANIC.FY2022 EARNINGS PER SHARE VIEW $5.71, REVENUE VIEW $32.97 BILLION -- REFINITIV IBES DATA.QTRLY NEUROSCIENCE REVENUE OF $2.136 BILLION INCREASED 4% AS REPORTED AND 3% ORGANIC.

Medtronic Announces Early Data For Intrepid Transcatheter Mitral Valve Replacement System

Nov 6 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC ANNOUNCES EARLY DATA FOR THE INTREPID™ TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR) SYSTEM USING NEW TRANSFEMORAL DELIVERY SYSTEM.TRANSFEMORAL ACCESS ADDED INTO LANDMARK APOLLO PIVOTAL TRIAL FOLLOWING IDE APPROVAL FROM FDA.MEDTRONIC- DATA FROM FIRST 15 PATIENTS ENROLLED IN AN EARLY FEASIBILITY STUDY OF INTREPID TRANSFEMORAL SYSTEM SHOWED 100% SURVIVAL AND NO STROKE.INTREPID TMVR SYSTEM IS AVAILABLE FOR INVESTIGATIONAL USE ONLY AND IT IS NOT APPROVED FOR USE OUTSIDE OF CLINICAL STUDIES.

Medtronic Has Received Interim Data Analysis Notification About Co's ON MED Study

Oct 15 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC PLC - HAS RECEIVED NOTIFICATION FROM ITS ON MED STUDY INDEPENDENT DSMB IT HAS CONDUCTED PRESPECIFIED INTERIM DATA ANALYSIS.MEDTRONIC PLC - DSMB HAS RECOMMENDED THAT CLINICAL TRIAL ENROLLMENT CONTINUE AS PLANNED, UNTIL FULL, PREDEFINED SAMPLE SIZE IS REACHED.MEDTRONIC PLC - MANAGEMENT REMAINS CONFIDENT IN ITS OUTLOOK AND ITS PIPELINE, INCLUDING ITS RENAL DENERVATION PROGRAM..MEDTRONIC PLC - TODAY'S UPDATE DOES NOT IMPACT COMPANY'S FISCAL YEAR 2022 REVENUE AND EPS GUIDANCE.

Medtronic PLC Announces New Esg Targets In Its FY21 Integrated Performance Report And Unveils Refreshed Brand

Oct 12 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC ANNOUNCES NEW ESG TARGETS IN ITS FY21 INTEGRATED PERFORMANCE REPORT AND UNVEILS REFRESHED BRAND.MEDTRONIC PLC - SET A VITALITY INDEX GOAL THAT BY FY25, 20% OF MEDTRONIC REVENUE WILL FLOW FROM PRODUCTS AND THERAPIES RELEASED IN PRIOR 36 MONTHS.MEDTRONIC PLC - BY FY25, WILL COMPLETE PACKAGING IMPROVEMENTS TO REDUCE PACKAGING WASTE BY 25% FOR TARGETED HIGH-VOLUME PRODUCTS VERSUS A FY21 BASELINE.

Medtronic Plc Receives CE Mark Approval For Radial Artery Access Portfolio

Sept 28 (Reuters) - Medtronic PLC <MDT.N>::MEDTRONIC RECEIVES CE MARK APPROVAL FOR RADIAL ARTERY ACCESS PORTFOLIO.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up